TNF-308 G/A polymorphism and risk of systemic lupus erythematosus in the Polish population

References

• Pieterse E, van der Vlag J. Breaking immunological tolerance in systemic lupus erythematosus. Front Immunol. 2014;5:164.
   PubMed Web of Science ®Google Scholar
• Anolik JH. B cell biology and dysfunction in SLE. Bull NYU Hosp Jt Dis. 2007;65(3):182–6.
   PubMedGoogle Scholar
• Crispín JC, Tsokos GC. Novel molecular targets in the treatment of systemic lupus erythematosus. Autoimmun Rev. 2008;7(3): 256–61.
   PubMed Web of Science ®Google Scholar
• Januchowski R, Wudarski M, Chwalińska-Sadowska H, Jagodzinski PP. Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4 + T cells of patients with systemic lupus erythematosus. Clin Rheumatol. 2008;27(1):21–7.
   PubMed Web of Science ®Google Scholar
• Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 2003;48(12):3475–86.
   PubMed Web of Science ®Google Scholar
• Costa-Reis P, Sullivan KE. Genetics and epigenetics of systemic lupus erythematosus. Curr Rheumatol Rep. 2013;15(9):369.
   PubMedGoogle Scholar
• Jönsen A, Bengtsson AA, Nived O, Truedsson L, Sturfelt G. Gene-environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity. 2007;40(8):613–7.
   PubMed Web of Science ®Google Scholar
• Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992;35(3):311–8.
   PubMed Web of Science ®Google Scholar
• Byrne JC, Ní Gabhann J, Lazzari E, Mahony R, Smith S, Stacey K, et al. Genetics of SLE: functional relevance for monocytes/macrophages in disease. Clin Dev Immunol. 2012;2012(2012):582352.
   PubMedGoogle Scholar
• Vaughn SE, Kottyan LC, Munroe ME, Harley JB. Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways. J Leukoc Biol. 2012;92(3):577–91.
   PubMed Web of Science ®Google Scholar
• Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol. 2010;6(12):683–92.
   PubMed Web of Science ®Google Scholar
• Lourenço EV, La Cava A. Cytokines in systemic lupus erythematosus. Curr Mol Med. 2009;9(3):242–54.
   PubMed Web of Science ®Google Scholar
• Aringer M, Smolen JS. Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus. Arthritis Res Ther. 2003;5(4):172–7.
   PubMed Web of Science ®Google Scholar
• Yap DYH, Lai KN. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol. 2010;2010(2010):365083.
   PubMedGoogle Scholar
• Alvarado-de la Barrera C, Alcocer-Varela J, Richaud-Patin Y, Alarcón-Segovia D, Llorente L. Differential oncogene and TNF-alpha mRNA expression in bone marrow cells from systemic lupus erythematosus patients. Scand J Immunol. 1998;48(5):551–6.
   PubMed Web of Science ®Google Scholar
• Pitidhammabhorn D, Kantachuvesiri S, Totemchokchyakarn K, Kitiyanant Y, Ubol S. Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway. Clin Rheumatol. 2006;25(5): 705–14.
   PubMed Web of Science ®Google Scholar
• Wozniacka A, Lesiak A, Boncela J, Smolarczyk K, McCauliffe DP, Sysa-Jedrzejowska A. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus. Br J Dermatol. 2008;159(5): 1124–30.
   PubMed Web of Science ®Google Scholar
• Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, et al. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol. 1997;24(2):303–8.
   PubMed Web of Science ®Google Scholar
• Jacob CO, McDevitt HO. McDevitt Tumor necrosis factor-alpha in murine autoimmune ‘lupus’ nephritis. Nature. 1988;331(6514): 356–8.
   PubMed Web of Science ®Google Scholar
• Segal R, Dayan M, Zinger H, Mozes E. Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNF alpha monoclonal antibody and by pentoxiphylline. Lupus. 2001;10(1):23–31.
   PubMed Web of Science ®Google Scholar
• Postal M, Appenzeller S. The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus. Cytokine. 2011;56(3):537–43.
   PubMed Web of Science ®Google Scholar
• Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, et al. Genetic polymorphisms in tumor necrosis factor (TNF) -alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol. 2004;65:622–31.
   PubMed Web of Science ®Google Scholar
• Schotte H, Willeke P, Tidow N, Domschke W, Assmann G, Gaubitz M et al. Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3. Scand J Rheumatol. 2005;34(2):114–21.
   PubMed Web of Science ®Google Scholar
• Ahmed HH, Taha FM, Darweesh Hel-S Morsi HM. Association between TNF promoter -308 G > A and LTA 252 A> G polymorphisms and systemic lupus erythematosus. Mol Biol Rep. 2014;41(4): 2029–36.
   PubMed Web of Science ®Google Scholar
• Angelo HD, da Silva HA, Asano NM, Muniz MT, de Mascena Diniz Maia M, de Souza PR. Tumor necrosis factor alpha promoter polymorphism -308 G/A in Brazilian patients with systemic lupus erythematosus. Hum Immunol. 2012;73(11):1166–70.
   PubMed Web of Science ®Google Scholar
• Jiménez-Morales S, Velázquez-Cruz R, Ramírez-Bello J, Bonilla-González E, Romero-Hidalgo S, Escamilla-Guerrero G, et al. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol. 2009;70(4):251–6.
   PubMed Web of Science ®Google Scholar
• Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum. 1997;40(12):2207–11.
   PubMed Web of Science ®Google Scholar
• Azizah MR, Kuak SH, Ainol SS, Rahim MN, Normaznah Y, Norella K. Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus. Asian Pac J Allergy Immunol. 2004;22(2–3):159–63.
   PubMed Web of Science ®Google Scholar
• Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 2000;43(1):129–34.
   PubMed Web of Science ®Google Scholar
• Lin YJ, Chen RH, Wan L, Sheu JC, Huang CM, Lin CW, et al. Association of TNF-α gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus. 2009;18(11):974–9.
   PubMed Web of Science ®Google Scholar
• Guarnizo-Zuccardi P, Lopez Y, Giraldo M, Garcia N, Rodriguez L, Ramirez L, et al. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens. 2007;70(5):376–82.
   PubMed Web of Science ®Google Scholar
• Santos MJ, Carmona-Fernandes D, Caetano-Lopes J, Perpétuo IP, Vidal B, Capela S, et al.TNF promoter -308 G> A and LTA 252 A> G polymorphisms in Portuguese patients with systemic lupus erythematosus. Rheumatol Int. 2012;32(8):2239–44.
   PubMed Web of Science ®Google Scholar
• van der Linden MW, van der Slik AR, Zanelli E, Giphart MJ, Pieterman E, Schreuder GM, et al. Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus. Genes Immun. 2001;2(7):373–80.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630–40.
   PubMed Web of Science ®Google Scholar
• Scheurich P, Thoma B, Ucer U, Pfizenmaier K. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol. 1987;138(6):1786–90.
   PubMed Web of Science ®Google Scholar
• Aringer M, Smolen JS. Therapeutic blockade of TNF in patients with SLE-promising or crazy? Autoimmun Rev. 2012;11(5):321–5.
   PubMed Web of Science ®Google Scholar
• Gordon C, Ranges GE, Greenspan JS, Wofsy D.Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol. 1989;52(3):421–34.
   PubMedGoogle Scholar
• Kontoyiannis D, Kollias G.Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur J Immunol. 2000;30(7):2038–47.
   PubMed Web of Science ®Google Scholar
• Boswell JM, Yui MA, Burt DW, Kelley VE. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol. 1988;141(9):3050–4.
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Kreft B, Kelley VR.Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms. Kidney Int. 1995, 47(1):122–30.
   PubMed Web of Science ®Google Scholar
• Su X, Zhou T, Yang P, Edwards CK III, Mountz JD. Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor. Arthritis Rheum. 1998, 41:139–49.
   PubMed Web of Science ®Google Scholar
• Joseph A, Brasington R, Kahl L, Ranganathan P, Cheng TP, Atkinson J. Immunologic rheumatic disorders. J Allergy Clin Immunol. 2010;125(2 suppl 2):S204–15.
   PubMed Web of Science ®Google Scholar
• Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, et al. Etanercept as monotherapy in patients with psoriasis. New Eng. J Med. 2003;349(21):2014–22.
   Google Scholar
• Komata T, Tsuchiya N, Matsushita M, Hagiwara K, Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens. 1999;53(6):527–33.
   PubMed Web of Science ®Google Scholar
• Morita C, Horiuchi T, Tsukamoto H, Hatta N, Kikuchi Y, Arinobu Y, et al. Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum. 2001;44(12):2819–27
   PubMed Web of Science ®Google Scholar
• Horiuchi T, Kiyohara C, Tsukamoto H, Sawabe T, Furugo I, Yoshizawa S, et al. A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis. Ann Rheum Dis. 2007;66(3):320–4.
   PubMed Web of Science ®Google Scholar
• Lee YH, Harley JB, Nath SK. Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet. 2006;14(3):364–71.
   PubMed Web of Science ®Google Scholar
• Zou YF, Feng XL, Tao JH, Su H, Pan FM, Liao FF et al. Meta-analysis of TNF-α promoter -308A/G polymorphism and SLE susceptibility in Asian populations. Rheumatol Int. 2011;31(8):1055–64.
   PubMed Web of Science ®Google Scholar
• Fujimura T, Hirose S, Jiang Y, Kodera S, Ohmuro H, Zhang D, et al. Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE). Int Immunol. 1998;10(10):1467–72.
   PubMed Web of Science ®Google Scholar
• Wang M, Dong Y, Huang S. Study on the association between tumor necrosis factor alpha gene polymorphism and systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi. 1999;38(6):393–6.
   PubMedGoogle Scholar
• Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol. 2005;32(2):219–24.
   PubMed Web of Science ®Google Scholar
• Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNF-alpha, LT-alpha, and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun. 2000;1(3):185–90.
   PubMed Web of Science ®Google Scholar
• Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1(5):353.
   PubMedGoogle Scholar
• Debets JM, Van der Linden CJ, Dieteren IE, Leeuwenberg JF, Buurman WA. Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol. 1988;141(4):1197–201.
   PubMed Web of Science ®Google Scholar
• Baud L, Fouqueray B, Philippe C. Glomerular expression of tumor necrosis factor alpha (TNF-alpha) and of its receptors. C R Seances Soc Biol Fil. 1993;187(4):434–9.
   PubMedGoogle Scholar
• Toonen EJ, Barrera P, Fransen J, de Brouwer AP, Eijsbouts AM, Miossec P, et al. Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis. Arthritis Res Ther. 2012;14(6): R264.
   PubMed Web of Science ®Google Scholar